PEIJIA MEDICAL LIMITED

Press Releases Peijia Medical Limited

Equities

9996

KYG6981F1090

Delayed Hong Kong S.E. Other stock markets 01:36:22 2024-07-11 am EDT			5-day change	1st Jan Change
2.47 ^HKD	+7.39%		+4.66%	-66.58%

Jun. 23	Peijia Medical Limited commences an Equity Buyback Plan for 67,885,680 shares, representing 10% of its issued share capital, under the authorization approved on May 25, 2023.	CI
Jun. 20	Peijia Medical Launches Share Buyback Plan	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Peijia Medical Announces 2023 Audited Results Announcement	Jun. 18	AQ
Peijia Medical Reports Audited 2023 Financial Results and Resumes Trading	Jun. 17	PR
Peijia Medical releases 2023 interim results, sales revenue grows rapidly and gross profit margin increases significantly	23-09-04	AQ
Peijia Medical Announces 2023 Interim Results	23-08-31	AQ
Peijia Medical Records Revenue Growth of 83.7% Year-over-Year in 2022	23-04-03	AQ
Peijia Medical Limited and inQB8 Medical Technologies, LLC report Successful First-in-Human implantation of MonarQ Transcatheter Tricuspid Valve Replacement System	22-11-28	AQ
Peijia Medical Announces 2022 Interim Results: TaurusOne(R) and TaurusElite(R) Repeatedly Sets New Monthly Highs in Implantation Volume	22-08-21	AQ
Peijia Medical Obtained Exclusive License for JenaValve's Trilogy TAVR System for Treating AR in the Greater China Region	22-01-19	PR
Peijia Medical : Engages Professor Saibal Kar as Exclusive Consultant	21-09-06	PR
Peijia Medical : VOLUNTARY ANNOUNCEMENT STRATEGIC INVESTMENT IN SUTRA MEDICAL	21-08-26	PU
Peijia Medical : With the Second-Generation transcatheter aortic valve replacement system approved for marketing, Peijia Medical leads China into the "Retrievable Era" using TAVR products	21-06-26	PR
Peijia Medical : and CR PHARMA COMM Sign Memorandum of Strategic Cooperation	21-06-04	PR
Peijia Medical :'s TaurusOne® Transcatheter Aortic Valve Replacement System Approved for Commercialization	21-04-24	PR
Peijia Medical : VOLUNTARY ANNOUNCEMENT Update on NMPA Approval for Registration Application of TaurusOne	21-04-20	PU
Peijia Medical : PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; PROPOSED RE-ELECTION OF RETIRING DIRECTORS; AND NOTICE OF ANNUAL GENERAL MEETING	21-04-20	PU
Peijia Medical : VOLUNTARY ANNOUNCEMENT RELEASE OF PARTIAL CLINICAL DATA OF FEASIBILITY STUDIES ON THE HIGHLIFE SAS TRANSCATHETER MITRAL VALVE REPLACEMENT SYSTEM	21-04-19	PU
Peijia Medical : Successfully Commenced Animal Study for its Mitral Valve Edge-to-Edge Repair Product	20-12-08	PR
Peijia Medical : Interim Report 2020	20-09-23	PU
Peijia Medical : VOLUNTARY ANNOUNCEMENT - Completion of Patient Enrollment for the Clinical Trial of TaurusElite	20-09-17	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Secure my Investments

fermer